APO E analogs and methods for their use
US7947645B2 · kind B2 · utility
5Cited by
10References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 2, 2005 |
| Grant date | May 24, 2011 |
| Priority date | — |
| Expiry date | Jan 7, 2027 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel ApoE-protein transduction domain conjugates are disclosed which are useful for treating disorders including CNS inflammation, traumatic brain injury, cerebral ischema, Alzheimer's Disease and other brain disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.